alopecia areata.
Conditions
Interventions
Intervention group: Topical minoxidil nanosuspention.
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Signature of written consent for participation in the study 2-Age between 18-55 years 3-The presence of alopecia androgenetic in male or female 4-There is no other disorder that causes hair loss such as telogeny, echolinate or scarring hair (like lichen planus) Class 1-4 in the Fitzpatrick Classification for Skin Type and Grade 3-6 Hair Loss for Men in the Norwood Hamilton Classification and Grade 2-3 Hair Loss for Women in the Ludwing Classification, Non-Use of Finasteride, Anti-Androgenetics, Local Estrogen , Progesterone, tamoxifen, anabolic steroids, potent potent medications for hyperkeratosis, oral glucocorticoid, lithium, phenothiazines within 3 months before the start of the study
Exclusion criteria
Exclusion criteria: 1-Pregnancy 2-lactation 3-Using of anabolic steroids in the last 6month 4-Using of topical minoxidil in the last 6month 5-Using of antiandrogenetic drugs in the last 6 month 6-Using of the drugs who make hyper keratosis as like as systemic corticosteroids in the last 6 month 7-Dont be principled to curative protocol 8-Hair transplantation 9-Collagen vascular disease or HIV 10-Endocrinopathy like PCO, Hypotyroid
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair density. Timepoint: 0,2,4,6 months. Method of measurement: Phototyrographic method.;Diagonal hair shaft. Timepoint: 0,2,4,6. Method of measurement: Phototyrographic method.;Patient satisfaction. Timepoint: 2,4,6 months. Method of measurement: questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache. Timepoint: 2,4,6 months. Method of measurement: Ask the patient.;Erythema - redness-itching. Timepoint: 0,2,4,6 month. Method of measurement: Ask the patient.;Hypopigmentation, hyperpigmentation. Timepoint: 0,2,4,6 month. Method of measurement: Evaluate by observation and Ask the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahla Mirzaeei
Kermanshah University of Medical Sciences
Outcome results
None listed